BTG (LON:BTG) Stock Price Crosses Above 200-Day Moving Average – Here’s What Happened

BTG plc (LON:BTG)’s share price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 0 and traded as high as GBX 120. BTG shares last traded at GBX 118.50, with a volume of 148,552 shares.

Wall Street Analyst Weigh In

Separately, Shore Capital Group reissued a “house stock” rating on shares of BTG in a research report on Tuesday, February 3rd.

BTG Stock Performance

The company has a market capitalization of £190.27 million and a PE ratio of 19.75.

BTG Company Profile

BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications. This segment also provides interventional vascular products consisting of EKOS system, an ultrasonic catheter drug delivery device used in the treatment of blood clots; Varithena for the treatment of varicose veins; and PneumRx Coil for the treatment of emphysema, a debilitating lung disease.